Stroke and cerebrovascular disease
Clinical research activity is centered on ischemic stroke, with interest in the treatment of acute brain infarction and the reduction of infarct burden after the event.
- Acute ischemic stroke
- Subacute stroke recovery
- Infarct volume assessment
The sponsor’s work reflects a focused involvement in hospital-based neurology and vascular medicine, particularly where early post-stroke intervention and brain tissue preservation are clinically relevant.
Cell-based therapy and regenerative medicine
Research interest extends to CD34+ cells and their use in intra-arterial delivery for neurological injury, highlighting a therapeutic focus on cellular approaches in stroke care.
- CD34+ cells
- Intra-arterial administration
- Cellular neurorepair
This area connects hematopoietic progenitor cells with regenerative therapies aimed at supporting recovery in damaged brain tissue.
Neurovascular intervention
The sponsor is involved in research at the intersection of neurology and interventional vascular treatment, with attention to targeted delivery into the cerebral circulation.
- Cerebral circulation
- Endovascular access
- Brain perfusion
Its clinical interest lies in approaches relevant to neurological salvage after vascular occlusion, especially in the early period following stroke onset.
